学校首页 | 学院首页 
         
刘圣智

姓名:刘圣智

性别:女

职称:副教授

招生院所:药学院

招生类型:学术学位(硕)

招生专业:药理学

研究方向名称:肿瘤药理学

电子信箱:szliu@ccmu.edu.cn

个人简介

本人研究乳腺癌骨转移的治疗及机制的研究,特别是肿瘤与骨微环境的相互作用,及开发有抑制癌细胞骨转移和骨保护双重作用的药物。其中以第一以及通讯作者身份在包括Bone Research,Cancer Research和Theranostics上发表SCI文章11篇,累计影响因子88余分。参与发表SCI论文30余篇。

教育经历

2015.5-2018.6,美国印第安纳大学与普渡大学联合学校,生物医学工程系,联合培养博士

2013.9-2018.6,哈尔滨医科大学,药学院,药理学,博士

2008.9-2013.6,哈尔滨医科大学,药学院,临床药学,学士

工作经历

2021.9-至今,首都医科大学药学院,药理系副教授

2018.6-2020.6,美国印第安纳大学与普渡大学联合学校,生物医学工程系,博士后

重要学术论文:

1. Leran Tao, Wenfei Zhang, Yaning Chen, Zicheng Wang, Xinyu Zhao*, Shengzhi Liu*. The clinical andgenetic profiles,management,and treatmentoutcomes offamilialexudativevitreoretinopathy. Survey of Ophthalmology. 2026, Accepted. IF=5.9

2. Shengzhi Liu*, Di Wu, Kazumasa Minami, Jing Liu, Sungsoo Na, Uma K. Aryal, Marxa L. Figueiredo, Alexander G. Robling, Bai-Yan Li, and Hiroki Yokota*. Induced Tumor-Suppressing (iTS) Cell-Based Approach for Protecting the Bone from Advanced Prostate Cancer. Biomolecules. 2026 Feb 3;16(2):240.IF=5.6

3. Yaning Chen, Zicheng Wang, Yu Sun, Xinshi Li, Yuji Wang* and Shengzhi Liu*. Inhibition of Breast Cancer Bone Metastasis by LRP5-Overexpressing Osteocytes via the LIMA1/MYO5B Signaling Axis. Int. J. Mol. Sci. 2026 Jan 13;27(2):777. IF=4.9

4. Lichun Zhao#, Wenhao Weng#, Mengyue Ni, Haoyu Shen, Shuai Zhang, Yaning Chen, Ruining Jia, Linzi Fan, Yuanhui Mao, Linyin Qin, Shengzhi Liu*, Yuji Wang*. Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis. Biomed Pharmacother. 2024 Nov 8:181:117574. IF=7.419

5. Yan Feng#, Shengzhi Liu#, Rongrong Zha, Xun Sun, Kexin Li, Di Wu, Uma K Aryal, Michael Koch, Bai-Yan Li, Hiroki Yokota. Prostate cancer-associated urinary proteomes differ before and after prostatectomy, Ther Adv Med Oncol, 2022 Oct 27:14:17588359221131532. IF=4.3

6. Shengzhi Liu*, Xun Sun, Kexin Li, Rongrong Zha, Yan Feng, Tomohiko Sano, Chuanpeng Dong, Yunlong Liu, Uma K Aryal, Akihiro Sudo, Bai-Yan Li, Hiroki Yokota*, Generation of the tumor-suppressive secretome from tumor cells. Theranostics, 2021, 11:8517-8534. IF=11.556

7. Shengzhi Liu*, Di Wu, Xun Sun, Yao Fan, Rongrong Zha, Aydin Jalali, Yan Feng, Kexin Li, Tomohiko Sano, Nicole Vike, Fangjia Li, Joseph Rispoli, Akihiro Sudo, Jing Liu, Alexander Robling, Harikrishna Nakshatri, Bai-Yan Li, Hiroki Yokota*, Overexpression of Lrp5 enhanced anti-breast cancer effects of osteocytes in the bone. Bone Research, 2021, 9(1):32. IF=12.35

承担重要项目

1.82203641,Lrp5过表达骨细胞通过调控LIMA1/MYO5B信号轴抑制乳腺癌骨转移的机制研究,国家自然科学基金 青年基金项目,30万,2022/01-2024/12,主持

2.KM202310025024,p53介导骨髓间充质千细胞调控 MSN/CD47信号轴抑制乳腺癌骨转移的机制研究,市教委一般科研项目,15万,2022/01-2024/12,主持



字号: 小 中 大 打印
                           
版权所有:首都医科大学药学院
联系电话:010-83911532 传真:010-83911533 联系地址:北京市右安门外西头条10号 邮编:100069